For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Sun Pharma Fall 6% On US FDA Warning

|

Shares in Sun Pharma fell a huge 6 per cent, after the company said that it had received a warning letter for its Halol Plant from the US FDA.

Sun Pharma Fall 6% On US FDA Warning
The shares were last trading at Rs 737, down almost 6 per cent over Friday's close. Commenting on the development, Dilip Shanghvi, Managing Director, Sun Pharma said, "While our team is working hard to ensure that the commitments made to the US FDA in September 2014 are fully completed, we will continue to cooperate with the US FDA and undertake any additional steps necessary to ensure that the US Agency is completely satisfied with our remediation of the Halol facility.
 

Sun Pharma has always ensured that its products are safe and effective and there is no doubt on the safety of our products in the market. We are pledged to being cGMP compliant and are committed to continuing to supply our customers and patients across the world with quality products that meet all specifications."

GoodReturns.in

Read more about: sun pharma us fda
Story first published: Monday, December 21, 2015, 10:18 [IST]
Company Search
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more